Ami Klin, Ph.D.
Georgia Research Alliance Eminent Scholar Professor and Chief of the Division of Autism and Developmental Disabilities at Emory University School of Medicine

Ami Klin, Ph.D. is the Georgia Research Alliance Eminent Scholar Professor and Chief of the Division of Autism and Developmental Disabilities at Emory University School of Medicine, and Director of the Marcus Autism Center, Children’s Healthcare of Atlanta. He obtained his Ph.D. from the University of London, and completed clinical and research post-doctoral fellowships at the Yale Child Study Center. He directed the Autism Program at the Yale Child Study Center, Yale University School of Medicine until 2010, where he was the Harris Professor of Child Psychology & Psychiatry. The Marcus Autism Center is one of the largest centers of clinical care in the country, providing a broad range of diagnostic and treatment services, and is also a National Institutes of Health Autism Center of Excellence, with a comprehensive interdisciplinary program of research in clinical and basic science. Dr. Klin’s primary research activities focus on social mind and social brain, and on developmental aspects of autism from infancy through adulthood. These studies include novel techniques such as the eye-tracking laboratories co-directed with Warren Jones, which allow researchers to see the world through the eyes of individuals with autism. These techniques are now being applied in the screening of toddlers at risk for autism. He is the author of over 250 publications in the field of autism and related conditions.

Disclosures:

Financial: Salary – Emory University School of Medicine and Honorarium for FSU Summer Institute

• Dr. Klin’s research is supported by grants from the National Institute of Mental Health.
• Dr. Klin’s research is also supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, The Marcus Foundation, and The J B Whitehead Foundation, as well as contributions from the Georgia Research Alliance.
• This presentation includes research related to investigational device development.
• Dr. Klin is an inventor and patent holder of investigational device technologies licensed in 2020 to EarliTec Diagnostics.
• EarliTec Diagnostics is a company that develops medical technologies for early diagnosis of autism and gives revenue to support treatment of children with autism. Dr. Klin is an equity holder in EarliTec Diagnostics.
• Dr. Klin’s external activity with EarliTec Diagnostics has been reviewed and approved by Emory University’s Conflict of Interest Review Office and by Emory University School of Medicine’s Dean’s Office.